Transverse Friction Massage Versus Instrumented Assisted Soft Tissue Mobilization in Quadratus Lumborum Syndrome
Comparative Effects of Transverse Friction Massage Versus Instrument-assisted Soft Tissue Mobilization on Pain, Range of Motion, and Posture in Patients With Quadratus Lumborum Syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 53200
- Hafiz Medical and diagnostic Center johar town Lahore
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age group between 18-40years
- Males only with target population was office workers
- NPRS>4
- Patients with a positional fault of the pelvis (lateral tilt)
- Patients having chronic LBP for more than six months
- Hyperirritable spot or taut band
- Positive jump sign for trigger points/ Referred pain related to the trigger point area
- Positive Lewis's functional palpation test for QL overactivity
- At least one trigger point in Quadratus lumborum
- Leg length discrepancy due to QL tightness
Exclusion Criteria:
- Congenital or acquired spinal deformities
- Spinal stenosis or radiculopathy
- Diagnosed disc prolapse
- Rheumatoid arthritis
- Any malignancy
- Recent history of surgery less than three months
- Acute infections
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Instrument assisted soft tissue mobilization
IASTM (Instrument-Assisted Soft Tissue Mobilization) in four specific body areas for four weeks.
The quadratus lumborum, posterior fascia, sacrum, hip lateral rotators, and hamstring bilaterally
|
IASTM (Instrument-Assisted Soft Tissue Mobilization) in four specific body areas.
The quadratus lumborum, posterior fascia, sacrum, hip lateral rotators, and hamstring bilaterally were these areas.
The subjects were asked to kneel directly on the bed to stimulate the lumbar posterior muscles erector spinae (iliocostalis, longissimus), lumborum, and multifidus.
At the same time, the IASTM treatment was applied to the rear fascia.
The same treatment was applied to the sacrum while the subject kneeled on the bed.
For hip lateral rotators, the IASTM treatment was applied to the gluteus maximus and gluteus medius while kneeling in a prone position with knee and hip flexion.
Similarly, for the hamstring bilaterally, the IASTM treatment was applied to the biceps femoris, semitendinosus, and semimembranosus while in a prone position.
The instrument was used for about 20 seconds in a direction parallel to the muscle fibers being treated and then for an additional 20 sec perpendicular to fibres
|
|
Active Comparator: Transverse friction massage
therapist will perform the transverse friction massage using their thumb to apply pressure across the muscle fibers of Quadratus Lumborum
|
patient was lying prone while the therapist administered a transverse friction massage to the affected area.
Before the massage, the therapist cleansed and dried the place to be treated, ensuring it was free of dirt or debris.
The therapist used their palpation skills to locate the site of pain and apply the massage technique accordingly.
The therapist performed the transverse friction massage using their thumb to apply pressure across the muscle fiber, with each repetition lasting for two minutes
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain rating scale(NPRS)
Time Frame: 8 weeks
|
The Numeric Pain Rating Scale (NPRS-11) has been widely used clinically to assess pain.
Universal pain screening with a 0-10 pain intensity numeric pain rating scale (NPRS) has been widely implemented in primary care.
The current study will use this scale to measure pain in the lumbosacral joint.
A numerical pain rating scale (NPRS) requires patients to rate their pain on a defined scale.
For example, 0 is no pain, and 10 is the worst.
NPRS scores ≤ 5 correspond to mild, 6-7 to moderate, and scores ≥8 to severe pain regarding pain-related interference with functioning
|
8 weeks
|
|
Range of motion
Time Frame: 8 weeks
|
The range of motion of the lumbosacral joint will be measured through an inclinometer for lumbar flexion (40-60 degrees), extension (20-35 degrees), and rotations (15-25 degrees) range of motion.
|
8 weeks
|
|
Posture
Time Frame: 8 weeks
|
Leg length discrepancy (LLD) is a "direct" measurement using a tape measure that can be utilized to measure the "true" leg length from the anterior superior iliac spine (ASIS) to the medial malleolus.
The "apparent" leg length is measured from the umbilicus to the medial malleolus, considered normal up to 1 cm, with mild LLD ranging from 1 to 2 cm, moderate LLD from 2 to 5 cm, and severe LLD greater than 5 cm
|
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Faiza Amjad, PhD, Riphah international universiy
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REC/RCR &AHS/24/0127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.